tradingkey.logo

Solventum Corp

SOLV
81.570USD
+0.890+1.10%
Close 12/19, 16:00ETQuotes delayed by 15 min
14.15BMarket Cap
9.31P/E TTM

Solventum Corp

81.570
+0.890+1.10%

More Details of Solventum Corp Company

Solventum Corporation is a global healthcare company developing, manufacturing, and commercializing a portfolio of solutions that leverage deep material science, data science, and digital capabilities to address critical customer needs. The Company’s segments include MedSurg, Dental Solutions, and Health Information System. MedSurg is a provider of solutions including negative pressure wound therapy, advanced wound dressings, advanced skin care, I.V. site management, sterilization assurance, temperature management, surgical supplies, medical tapes and wraps, stethoscopes, medical electrodes, and medical technologies Original Equipment Manufacturer (OEM). Dental Solutions is a provider of a comprehensive suite of dental and orthodontic products including brackets, aligners, and restorative cement. Health Information Systems provides healthcare systems with software solutions, including computer-assisted physician documentation, and direct-to-bill and coding automation.

Solventum Corp Info

Ticker SymbolSOLV
Company nameSolventum Corp
IPO dateMar 26, 2024
CEOHanson (Bryan C)
Number of employees22000
Security typeOrdinary Share
Fiscal year-endMar 26
AddressC/O 3M Company
CityST. PAUL
Stock exchangeNASDAQ OMX NASDAQ Basic NYSE
CountryUnited States of America
Postal code55144-1000
Phone16517331110
Websitehttps://www.solventum.com/en-us/home/
Ticker SymbolSOLV
IPO dateMar 26, 2024
CEOHanson (Bryan C)

Company Executives of Solventum Corp

Name
Name/Position
Position
Shareholding
Change
Mr. Wayde D. McMillan
Mr. Wayde D. McMillan
Chief Financial Officer
Chief Financial Officer
37.52K
+66.84%
Ms. Amy Landucci
Ms. Amy Landucci
Chief Information and Digital Officer
Chief Information and Digital Officer
18.95K
+14.54%
Mr. Paul S. Harrington
Mr. Paul S. Harrington
Chief Supply Chain Officer
Chief Supply Chain Officer
15.94K
+59.30%
Ms. Tammy L. Gomez
Ms. Tammy L. Gomez
Chief Human Resources Officer
Chief Human Resources Officer
5.66K
+88.88%
Mr. Chris Barry
Mr. Chris Barry
Executive Vice President and Group President, Medical Surgical
Executive Vice President and Group President, Medical Surgical
4.62K
--
Mr. Carlos Alban
Mr. Carlos Alban
Independent Director
Independent Director
3.56K
--
Mr. John H. Weiland
Mr. John H. Weiland
Independent Director
Independent Director
3.56K
--
Mr. Darryl L. Wilson
Mr. Darryl L. Wilson
Independent Director
Independent Director
3.56K
--
Ms. Karen J. May, CPA
Ms. Karen J. May, CPA
Independent Director
Independent Director
3.56K
--
Mr. Glenn A. Eisenberg
Mr. Glenn A. Eisenberg
Independent Director
Independent Director
3.56K
--
View more
Name
Name/Position
Position
Shareholding
Change
Mr. Wayde D. McMillan
Mr. Wayde D. McMillan
Chief Financial Officer
Chief Financial Officer
37.52K
+66.84%
Ms. Amy Landucci
Ms. Amy Landucci
Chief Information and Digital Officer
Chief Information and Digital Officer
18.95K
+14.54%
Mr. Paul S. Harrington
Mr. Paul S. Harrington
Chief Supply Chain Officer
Chief Supply Chain Officer
15.94K
+59.30%
Ms. Tammy L. Gomez
Ms. Tammy L. Gomez
Chief Human Resources Officer
Chief Human Resources Officer
5.66K
+88.88%
Mr. Chris Barry
Mr. Chris Barry
Executive Vice President and Group President, Medical Surgical
Executive Vice President and Group President, Medical Surgical
4.62K
--
Mr. Carlos Alban
Mr. Carlos Alban
Independent Director
Independent Director
3.56K
--

Revenue Breakdown

Currency: USDUpdated: Mon, Oct 6
Currency: USDUpdated: Mon, Oct 6
FY2025Q2
FY2025Q1
FY2024
FY2024Q2
FY2024Q1
FY2023
FY2022
FY2021
FY2020
Relevant data have not been disclosed by the company yet.
By RegionUSD
Name
Revenue
Proportion
United States
1.19B
55.02%
International
972.00M
44.98%
By Business
By Region
Relevant data have not been disclosed by the company yet.

Shareholding Stats

Updated: Sun, Nov 16
Updated: Sun, Nov 16
Shareholders
Shareholder Types
Shareholders
Shareholders
Proportion
3M Co
14.74%
The Vanguard Group, Inc.
9.83%
Independent Franchise Partners LLP
7.44%
Trian Fund Management, L.P.
4.88%
BlackRock Institutional Trust Company, N.A.
4.28%
Other
58.83%
Shareholders
Shareholders
Proportion
3M Co
14.74%
The Vanguard Group, Inc.
9.83%
Independent Franchise Partners LLP
7.44%
Trian Fund Management, L.P.
4.88%
BlackRock Institutional Trust Company, N.A.
4.28%
Other
58.83%
Shareholder Types
Shareholders
Proportion
Investment Advisor
38.18%
Investment Advisor/Hedge Fund
18.33%
Corporation
14.77%
Hedge Fund
9.34%
Research Firm
1.78%
Insurance Company
1.25%
Pension Fund
1.24%
Bank and Trust
1.12%
Sovereign Wealth Fund
1.10%
Other
12.88%

Institutional Shareholding

Updated: Wed, Oct 1
Updated: Wed, Oct 1
Reporting Period
No. of institutions
Shares Held
Proportion
Change
2025Q3
1679
116.62M
67.26%
-5.60M
2025Q2
1645
152.52M
88.14%
-244.96K
2025Q1
1620
152.60M
88.20%
+1.67M
2024Q4
1529
146.34M
84.59%
+493.48K
2024Q3
1406
142.85M
82.66%
+3.87M
2024Q2
1242
141.43M
81.89%
-74.84M
2024Q1
77
177.69M
102.88%
+177.69M

Shareholder Activity

Name
Shares Held
Proportion
Change
Chg %
Date
3M Co
25.57M
14.75%
-8.80M
-25.60%
Aug 15, 2025
The Vanguard Group, Inc.
16.19M
9.34%
+26.93K
+0.17%
Jun 30, 2025
Independent Franchise Partners LLP
10.14M
5.85%
+4.32M
+74.22%
Jun 30, 2025
Trian Fund Management, L.P.
8.46M
4.88%
--
--
Jun 30, 2025
BlackRock Institutional Trust Company, N.A.
6.93M
4%
-659.63K
-8.69%
Jun 30, 2025
State Street Investment Management (US)
6.11M
3.52%
-91.31K
-1.47%
Jun 30, 2025
Davis Selected Advisers, L.P.
5.49M
3.17%
+204.52K
+3.87%
Jun 30, 2025
Boston Partners
3.67M
2.12%
+308.78K
+9.18%
Jun 30, 2025
Geode Capital Management, L.L.C.
3.56M
2.06%
+36.66K
+1.04%
Jun 30, 2025
Invesco Capital Management LLC
2.34M
1.35%
-38.87K
-1.64%
Jun 30, 2025
View more

Related ETFs

Updated: Sat, Dec 6
Updated: Sat, Dec 6
Name
Proportion
Invesco S&P Spin-Off ETF
5.34%
Davis Select US Equity ETF
2.13%
Davis Select Worldwide ETF
1.94%
State Street SPDR S&P Health Care Equipment ETF
1.73%
Invesco S&P 500 Equal Weight Health Care ETF
1.58%
First Trust US Equity Opportunities ETF
1.04%
Pacer CFRA-Stovall Equal Weight Seasonal Rot Idx
0.72%
Motley Fool Next Index ETF
0.53%
WisdomTree US MidCap Fund
0.4%
VictoryShares US Small Mid Cap Value Momentum ETF
0.39%
View more
Invesco S&P Spin-Off ETF
Proportion5.34%
Davis Select US Equity ETF
Proportion2.13%
Davis Select Worldwide ETF
Proportion1.94%
State Street SPDR S&P Health Care Equipment ETF
Proportion1.73%
Invesco S&P 500 Equal Weight Health Care ETF
Proportion1.58%
First Trust US Equity Opportunities ETF
Proportion1.04%
Pacer CFRA-Stovall Equal Weight Seasonal Rot Idx
Proportion0.72%
Motley Fool Next Index ETF
Proportion0.53%
WisdomTree US MidCap Fund
Proportion0.4%
VictoryShares US Small Mid Cap Value Momentum ETF
Proportion0.39%

Dividend

A total of 0.00 USD has been distributed in dividends over the past 5 years.
Date
Dividend
Record Date
Payment Date
Ex-dividend Date
No Data

Stock Split

Date
Type
Ratio
No Data
Date
Type
Ratio
No Data

FAQs

Who are the top five shareholders of Solventum Corp?

The top five shareholders of Solventum Corp are:
3M Co holds 25.57M shares, accounting for 14.75% of the total shares.
The Vanguard Group, Inc. holds 16.19M shares, accounting for 9.34% of the total shares.
Independent Franchise Partners LLP holds 10.14M shares, accounting for 5.85% of the total shares.
Trian Fund Management, L.P. holds 8.46M shares, accounting for 4.88% of the total shares.
BlackRock Institutional Trust Company, N.A. holds 6.93M shares, accounting for 4.00% of the total shares.

What are the top three shareholder types of Solventum Corp?

The top three shareholder types of Solventum Corp are:
3M Co
The Vanguard Group, Inc.
Independent Franchise Partners LLP

How many institutions hold shares of Solventum Corp (SOLV)?

As of 2025Q3, 1679 institutions hold shares of Solventum Corp, with a combined market value of approximately 116.62M, accounting for 67.26% of the total shares. Compared to 2025Q2, institutional shareholding has increased by -20.88%.

What is the biggest source of revenue for Solventum Corp?

In FY2025Q2, the -- business generated the highest revenue for Solventum Corp, amounting to -- and accounting for --% of total revenue.
KeyAI